According to the International Diabetes Federation (IDF), more than 537 million adults aged 20 79 were affected by T2D globally in 2021, with an estimated global healthcare expenditure of USD 966 billion, representing a staggering 316% increase over the past 15 years
Safety and efficacy data in this population remain limited
With consistent support and expert care, I've made noticeable progress toward my personal wellness goals
The dosage charts in this guide are derived from Phase 2 and Phase 3 clinical trial protocols, not from approved prescribing information
Both FM and functional gastrointestinal disorders (FGIDs) are thought to be linked to dysfunction of autonomic nervous system, which can lead to central sensitization, and may have a mutual reinforcing effect [30, 31]
Anti-neuroinflammatory effects of fucoxanthin via inhibition of Akt/NF-B and MAPKs/AP-1 pathways and activation of PKA/CREB pathway in lipopolysaccharide-activated BV-2 microglial cells